IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

被引:1
|
作者
Mauricio Venegas [1 ]
Rodrigo A Villanueva [2 ]
Katherine González [1 ]
Javier Brahm [1 ]
机构
[1] Centro de Estudios Avanzados de las Hepatitis Virales,Sección de Gastroenterología,Departamento de Medicina,Hospital Clínico Universidad de Chile
[2] Centro de Estudios Avanzados de las Hepatitis Virales,Laboratorio de Virus Hepatitis,Programa de Virología,Instituto de Ciencias Biomédicas,Facultad de Medicina,Universidad de Chile
关键词
IL28B; Hepatitis C virus; Chile; Pegylated interferon; Ribavirin;
D O I
暂无
中图分类号
R512.63 [];
学科分类号
100401 ;
摘要
AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P < 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1.
引用
收藏
页码:3636 / 3639
页数:4
相关论文
共 50 条
  • [31] IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
    Fattovich, G.
    Covolo, L.
    Bibert, S.
    Askarieh, G.
    Lagging, M.
    Clement, S.
    Malerba, G.
    Pasino, M.
    Guido, M.
    Puoti, M.
    Gaeta, G. B.
    Santantonio, T.
    Raimondo, G.
    Bruno, R.
    Bochud, P. -Y.
    Donato, F.
    Negro, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (10) : 1162 - 1172
  • [32] Analysis of genetic determinants associated with therapy response against hepatitis C virus: first study of IL28B polymorphisms in Uruguayan patients
    Echeverria-Chagas, N.
    Fischer, S.
    Boschi, S.
    Uriarte, R.
    Angulo, J.
    Lopez-Lastra, M.
    Moratorio, G.
    Cristina, J.
    Moreno, P.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 24 - 25
  • [33] Sequence Analysis of the IL28A/IL28B Inverted Gene Duplication That Contains Polymorphisms Associated with Treatment Response in Hepatitis C Patients
    Reynolds, Jennifer M.
    Paciga, Sara A.
    Sanders, Frances A.
    Hyde, Craig L.
    Loomis, A. Katrina
    Johnston, Geoffrey I.
    PLOS ONE, 2012, 7 (01): : 271 - 278
  • [34] THE RELATIONSHIP BETWEEN HEPATIC STEATOSIS AND IL28B RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C
    Tillmann, H. L.
    Patel, K.
    Muir, A.
    Guy, C.
    Li, J. H.
    Lao, X. Q.
    Thompson, A. J.
    Clark, P. J.
    Gardner, S. D.
    McHutchison, J. G.
    McCarthy, J. J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S531 - S531
  • [35] IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
    Mayu Ohnishi
    Masataka Tsuge
    Tomohiko Kohno
    Yizhou Zhang
    Hiromi Abe
    Hideyuki Hyogo
    Yuki Kimura
    Daiki Miki
    Nobuhiko Hiraga
    Michio Imamura
    Shoichi Takahashi
    Hidenori Ochi
    C. Nelson Hayes
    Shinji Tanaka
    Koji Arihiro
    Kazuaki Chayama
    Journal of Gastroenterology, 2012, 47 : 834 - 844
  • [36] IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
    Andrzej Ciela
    Monika Bociaga-Jasik
    Iwona Sobczyk-Krupiarz
    Mikolaj K Glowacki
    Danuta Owczarek
    Dorota Cibor
    Marek Sanak
    Tomasz Mach
    World Journal of Gastroenterology, 2012, (35) : 4892 - 4897
  • [37] IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients
    Ohnishi, Mayu
    Tsuge, Masataka
    Kohno, Tomohiko
    Zhang, Yizhou
    Abe, Hiromi
    Hyogo, Hideyuki
    Kimura, Yuki
    Miki, Daiki
    Hiraga, Nobuhiko
    Imamura, Michio
    Takahashi, Shoichi
    Ochi, Hidenori
    Hayes, C. Nelson
    Tanaka, Shinji
    Arihiro, Koji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (07) : 834 - 844
  • [38] IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C
    Ciesla, Andrzej
    Bociaga-Jasik, Monika
    Sobczyk-Krupiarz, Iwona
    Glowacki, Mikolaj K.
    Owczarek, Danuta
    Cibor, Dorota
    Sanak, Marek
    Mach, Tomasz
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (35) : 4892 - 4897
  • [39] Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
    Staettermayer, A. F.
    Strassl, R.
    Maieron, A.
    Rutter, K.
    Stauber, R.
    Strasser, M.
    Beinhardt, S.
    Datz, C.
    Scherzer, T. -M.
    Steindl-Munda, P.
    Gschwantler, M.
    Trauner, M.
    Hofer, H.
    Ferenci, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 104 - 111
  • [40] IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population
    Martinez-Gomez, Laura E.
    Chavez-Tapia, Norberto C.
    Burguete-Garcia, Ana I.
    Aguilar-Olivos, Nancy
    Madrid-Marina, Vicente
    Roman-Bahena, Margarita
    Orbe-Orihuela, Citlalli
    Misael, Uribe
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2012, 11 (06) : 876 - 881